Skip to content
ETopical – Lifestyle
Author:
Dogwood Therapeutics, Inc.
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
April 15, 2026
←
Previous Page
1
2